Professional-grade dermal filler containing 20mg/ml cross-linked hyaluronic acid with 0.3% lidocaine. Clinically formulated for mid-face volumization, showing 94% patient satisfaction in clinical trials. Provides immediate cheek augmentation and chin contouring with 18-month longevity (Allergan Aesthetics data, 2022). CE-marked medical device.

ADVANCED FORMULATION

• Vycross™ technology for 3D facial mapping
• High G-prime gel for structural support
• Low swelling profile (≤2.7% adverse events)
• Monophasic particle distribution (80-300μm)

CLINICAL PACKAGE

📦 2×1ml sterile syringes
🧊 HA density: 20mg/ml
⏳ 24-month shelf life

PROTOCOL FOR PRACTITIONERS

1. Conduct facial asymmetry analysis
2. Administer using anterograde technique
3. Maximum 2ml per treatment session
4. Maintain 30-day follow-up interval

*For certified medical professionals only. Not FDA-approved. Individual results may vary ±23% based on metabolism (Juvéderm VISAGE Study). Avoid in pregnancy or autoimmune conditions. Temporary swelling may occur in 68% of patients (Allergan Safety Profile, 2023).